Editorial: Induced cell senescence as a therapeutic strategy for cancer treatment

被引:1
作者
He, Kaiyue [1 ]
Lu, Liyuan [1 ]
Jian, Yong-Ping [1 ]
Xu, Zhi-Xiang [1 ,2 ]
机构
[1] Henan Univ, Sch Life Sci, Kaifeng, Henan, Peoples R China
[2] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
基金
中国国家自然科学基金;
关键词
cell senescence; cell-cycle arrest; tumor suppressor genes; cancer treatment; tumor nanotherapeutics; IMMUNOTHERAPY;
D O I
10.3389/fonc.2022.1104877
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:4
相关论文
共 18 条
[1]   CELLULAR SENESCENCE: AGING, CANCER, AND INJURY [J].
Calcinotto, Arianna ;
Kohli, Jaskaren ;
Zagato, Elena ;
Pellegrini, Laura ;
Demaria, Marco ;
Alimonti, Andrea .
PHYSIOLOGICAL REVIEWS, 2019, 99 (02) :1047-1078
[2]   Cellular Senescence: Defining a Path Forward [J].
Gorgoulis, Vassilis ;
Adams, Peter D. ;
Alimonti, Andrea ;
Bennett, Dorothy C. ;
Bischof, Oliver ;
Bishop, Cleo ;
Campisi, Judith ;
Collado, Manuel ;
Evangelou, Konstantinos ;
Ferbeyre, Gerardo ;
Gil, Jesus ;
Hara, Eiji ;
Krizhanovsky, Valery ;
Jurk, Diana ;
Maier, Andrea B. ;
Narita, Masashi ;
Niedernhofer, Laura ;
Passos, Joao F. ;
Robbins, Paul D. ;
Schmitt, Clemens A. ;
Sedivy, John ;
Vougas, Konstantinos ;
von Zglinicki, Thomas ;
Zhou, Daohong ;
Serrano, Manuel ;
Demaria, Marco .
CELL, 2019, 179 (04) :813-827
[3]   Top 10 Challenges in Cancer Immunotherapy [J].
Hegde, Priti S. ;
Chen, Daniel S. .
IMMUNITY, 2020, 52 (01) :17-35
[4]   Mechanisms and functions of cellular senescence [J].
Herranz, Nicolas ;
Gil, Jesus .
JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (04) :1238-1246
[5]   Wnt signaling pathway in aging-related tissue fibrosis and therapies [J].
Hu, He-He ;
Cao, Gang ;
Wu, Xia-Qing ;
Vaziri, Nosratola D. ;
Zhao, Ying-Yong .
AGEING RESEARCH REVIEWS, 2020, 60
[6]   Cellular senescence: the good, the bad and the unknown [J].
Huang, Weijun ;
Hickson, LaTonya J. ;
Eirin, Alfonso ;
Kirkland, James L. ;
Lerman, Lilach O. .
NATURE REVIEWS NEPHROLOGY, 2022, 18 (10) :611-627
[7]   Senescence surveillance of pre-malignant hepatocytes limits liver cancer development [J].
Kang, Tae-Won ;
Yevsa, Tetyana ;
Woller, Norman ;
Hoenicke, Lisa ;
Wuestefeld, Torsten ;
Dauch, Daniel ;
Hohmeyer, Anja ;
Gereke, Marcus ;
Rudalska, Ramona ;
Potapova, Anna ;
Iken, Marcus ;
Vucur, Mihael ;
Weiss, Siegfried ;
Heikenwalder, Mathias ;
Khan, Sadaf ;
Gil, Jesus ;
Bruder, Dunja ;
Manns, Michael ;
Schirmacher, Peter ;
Tacke, Frank ;
Ott, Michael ;
Luedde, Tom ;
Longerich, Thomas ;
Kubicka, Stefan ;
Zender, Lars .
NATURE, 2011, 479 (7374) :547-551
[8]   A review of cancer immunotherapy toxicity [J].
Kennedy, Lucy Boyce ;
Salama, April K. S. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2020, 70 (02) :86-104
[9]   Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy [J].
Li, Wei ;
Peng, Anghui ;
Wu, Huajun ;
Quan, Yingyao ;
Li, Yong ;
Lu, Ligong ;
Cui, Min .
FRONTIERS IN IMMUNOLOGY, 2020, 11
[10]   A tumor suppressor enhancing module orchestrated by GATA4 denotes a therapeutic opportunity for GATA4 deficient HCC patients [J].
Lu, Feng ;
Zhou, Qian ;
Liu, Lu ;
Zeng, Guandi ;
Ci, Weimin ;
Liu, Wanting ;
Zhang, Gong ;
Zhang, Zhiyi ;
Wang, Peng ;
Zhang, Aiqun ;
Gao, Yunfei ;
Yu, Lei ;
He, Qingyu ;
Chen, Liang .
THERANOSTICS, 2020, 10 (02) :484-497